Showing metabocard for N-oleoyl-L-arginine (MMDBc0061068)
Microbial
Human
| Record Information | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Version | 2.0 | ||||||||||||
| Status | Detected and Quantified | ||||||||||||
| Creation Date | 2025-10-03 03:02:07 UTC | ||||||||||||
| Update Date | 2025-10-08 21:35:43 UTC | ||||||||||||
| Metabolite ID | MMDBc0061068 | ||||||||||||
| Metabolite Identification | |||||||||||||
| Common Name | N-oleoyl-L-arginine | ||||||||||||
| Description | N-oleoyl-L-arginine is a fatty acid amide belonging to the class of bioactive lipids. This compound features a long-chain oleoyl group esterified to the amino acid L-arginine, which contributes to its amphiphilic nature and potential interactions with biological membranes. The chemical structure of N-oleoyl-L-arginine includes a carboxylic acid moiety, an amine group, and a hydrocarbon tail, allowing it to participate in various biochemical pathways. It has been utilized as a drug-structure-directing agent in the synthesis of nanocarriers, specifically ArgC18@MSNs, which were characterized using techniques such as TEM, FTIR, and TGA (PMID:40835541 ). N-oleoyl-L-arginine is implicated in signaling pathways that involve nitric oxide production and may influence processes such as cell proliferation and apoptosis through its interactions with cellular receptors. Its unique structure and properties make it a subject of interest in drug delivery and therapeutic applications, highlighting its relevance in both chemistry and biology. | ||||||||||||
| Structure |  | ||||||||||||
| Synonyms | Not Available | ||||||||||||
| Molecular Formula | C24H46N4O3 | ||||||||||||
| Average Mass | 438.657 | ||||||||||||
| Monoisotopic Mass | 438.356991357 | ||||||||||||
| IUPAC Name | Not Available | ||||||||||||
| Traditional Name | Not Available | ||||||||||||
| CAS Registry Number | Not Available | ||||||||||||
| SMILES | Not Available | ||||||||||||
| InChI Identifier | Not Available | ||||||||||||
| InChI Key | YZYYKAWTXPUEGT-YUQDSPFASA-N | ||||||||||||
| Chemical Taxonomy | |||||||||||||
| Functional Ontology | |||||||||||||
| Not Available | |||||||||||||
| Physical Properties | |||||||||||||
| State | Not Available | ||||||||||||
| Predicted Properties | Not Available | ||||||||||||
| Spectra | |||||||||||||
| Not Available | |||||||||||||
| Biological Properties | |||||||||||||
| Cellular Locations | Not Available | ||||||||||||
| Biospecimen Locations | Not Available | ||||||||||||
| Tissue Locations | Not Available | ||||||||||||
| Associated OMIM IDs | |||||||||||||
| Human Proteins and Enzymes | |||||||||||||
| |||||||||||||
| Human Pathways | |||||||||||||
| Pathways |
| ||||||||||||
| Microbial Pathways | |||||||||||||
| Pathways | This table shows at most 5 pathways. For the full list of associated pathways: See All Associated Bacterial Pathways
| ||||||||||||
| Metabolic Reactions | |||||||||||||
Reactions This table shows at most 20 reactions. For the full list of associated reactions: See All Associated Reactions
| |||||||||||||
| Health Effects and Bioactivity | |||||||||||||
| |||||||||||||
| Microbial Sources | |||||||||||||
| |||||||||||||
| Exposure Sources | |||||||||||||
| Other Exposures |
| ||||||||||||
| Host Biospecimen and Location | |||||||||||||
| |||||||||||||
| External Links | |||||||||||||
| CMMC Knowledgebase | YZYYKAWTXPUEGT-YUQDSPFASA-N | ||||||||||||
| References | |||||||||||||
| Synthesis Reference | Not Available | ||||||||||||
| General References |
| ||||||||||||
